SMAM
MRNA icon

Sugar Maple Asset Management’s Moderna MRNA Stock Holding History

Sugar Maple Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,010
Closed -$738K – 92
2025
Q4 		$738K Buy
25,010
+8,010
+47% +$218K 0.5% 38
2025
Q3 		$439K Buy
+17,000
New +$474K 0.31% 54

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sugar Maple Asset Management's MRNA Position: Q1 2026 in Review

Sugar Maple Asset Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 25,010 shares — an estimated $738K sold.

Sugar Maple Asset Management first reported a position in MRNA in Q3 2025 and held it in 2 quarters. The position peaked at $738K in Q4 2025. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Sugar Maple Asset Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Sugar Maple Asset Management sold 25,010 Moderna shares in Q1 2026, an estimated $738K.
  • Sugar Maple Asset Management first reported a position in Moderna in Q3 2025 and held it in 2 quarters.
  • Sugar Maple Asset Management's Moderna position peaked at $738K in Q4 2025.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Sugar Maple Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.